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Abstract The functional analysis of chromosome 21
(Chr21) proteins is of great medical relevance. This refers,
in particular, to the trisomy of human Chr21, which results
in Down’s syndrome, a complex developmental and neu-
rodegenerative disease. In a previous study we analyzed 89
human Chr21 genes for the subcellular localization of their
encoded proteins using a transfected-cell array technique.
In the present study, the results of the follow-up investi-
gation are presented in which 52 human Chr21 genes were
over-expressed in HEK cells using the transfected-cell
array platform, and the effect of this protein over-expres-
sion on the induction of apoptosis has been analyzed. We
found that the over-expression of two Chr21 proteins
(claudin-14 and -8) induced cell death independent of the
classic caspase-mediated apoptosis. Our results strongly
suggest the functional involvement of claudins in the
control of the cell cycle and regulation of the cell death
induction mechanism.
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Introduction
With an incidence of approximately one in 700 live births,
Down’s syndrome (DS) is the most common genetic cause
of mental retardation [1]. DS, or trisomy 21, is caused by an
extra, third, copy of all or part of human chromosome 21
and the consequent over-expression of the proteins encoded
within it. The phenotype of Down’s syndrome includes
various organ malformations, stereotypic craniofacial
anomalies and brain malformations [2]. The molecular
analysis of this syndrome, however, poses a particular
challenge because the aneuploid region of Chr21 contains
genes of unknown functions. Genomic sequencing and
gene expression analyses of human Chr21 [3–7], as well as
studies of the transcriptome of DS mouse models [8–12],
provide a comprehensive resource for the systematic func-
tional characterization of Chr21 genes. However, the
functional characterization at the protein level has been
performed most often using protein prediction algorithms.
Therefore, the determination of the subcellular protein
distribution as well as the effects of protein over-expression
on cellular physiology would provide an important insight
into the function of human Chr21 genes.
In a previous study, we analyzed 89 human Chr21 genes
for the subcellular localization of their encoded proteins
using a transfected-cell array technique. The over-expres-
sion of several Chr21 genes was found to result in changes
in cellular phenotypes, such as the cell morphology and
proliferation [13]. To understand the underlying mecha-
nisms of these phenotypes, in the present study we inves-
tigated the effects of protein over-expression on induced
cell death using the same cell array technique. A novel
enhanced apoptosis assay was developed on the cell array
platform, allowing the efﬁcient, large-scale screening of
apoptosis regulators. This led to the discovery of cell death
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junction proteins, claudin-8 and -14, out of 52 human
chromosome 21 proteins. By using multiple assays that
utilize different detection principles for dying cells, we
were able to reveal a non-classic type of apoptosis induced
by claudins-8 and -14.
Materials and methods
Plasmid constructs and transfected-cell array assay
Protein expression constructs for 52 human chromosome
21 genes have been cloned and reverse transfected as
described previously [13]. Brieﬂy, each ORF was ampliﬁed
from cDNA clones and using the Gateway
TM cloning
technology (Invitrogen), the PCR products were ﬁnally
cloned into the pDEST
TM26 vector for protein over-
expression with a 69-Histidine (His6) tag at the N-termi-
nus. For the reverse transfection on cell arrays, the plas-
mids were ﬁrst diluted in a gelatin solution and printed onto
standard glass slides that were coated with poly-L-lysine
(Sigma). The spotted plasmid-slides were then treated with
Effectene transfection reagent (Qiagen) before adding the
HEK293T cells on the top for reverse transfection, as
described by Ziauddin and Sabatini [14]. The Chr21 pro-
teins were allowed to over-express on cell arrays for 48–
72 h before the cells were subjected to the apoptosis
detection assay.
Cell culture
Human HEK293T/17 (ATCC, CRL-11268) cells were
cultured in the DMEM medium (Invitrogen, Karlsruhe,
Germany) supplemented with 10% (v/v) fetal calf serum
(Biochrom, Berlin, Germany), L-glutamine (Sigma) and
gentamicin (Gibco Invitrogen, Karlsruhe, Germany) at
37C in a humidiﬁed 5% CO2 incubator. One day before
the transfection, 10 9 10e6 HEK293T cells per 10-cm dish
in 10 ml of medium were seeded out. For the cell array,
3.5 9 10e6 HEK293T cells were added on top of each
slide for the reverse transfection.
Immunoﬂuorescence
The recombinant Chr21 proteins were detected with
PentaHis Alexa488 or Alexa555-conjugated mouse anti-
body (Qiagen). The mouse anti-Bax antibody (clone 3,
BD Biosciences) was used to evaluate the expression
level of the exogenous Bax protein. After ﬁxation with
3.7% (v/v) paraformaldehyde, the cell arrays were per-
meabilized with 0.1% (v/v) Triton X-100 or 0.5% (w/v)
saponin and subsequently blocked for 1 h at room tem-
perature using 5% (w/v) bovine serum albumin or 5% (v/
v) normal serum from the host species of the ﬂuorophor-
labeled antibodies. The cell arrays were then incubated
with the mouse primary antibodies. For the detection of
Bax protein, an incubation with the secondary antibody,
Alexa488 or Alexa568 goat anti-mouse IgG antibody
(Molecular Probes), was performed. Each cell array slide
was incubated with DAPI before the ﬁnal washing and




The cell arrays were ﬁxed with 3.7% formaldehyde for
20 min at room temperature. After two PBS washes, the
permeabilization was performed with 0.1% Triton X-100 in
0.1% sodium citrate for 2 min at room temperature. After
washing with PBS, the appropriate volume of freshly pre-
pared TUNEL reaction mixture (In Situ Cell Death
Detection Kit, Fluorescein, Roche) was added to the slides
and the slides were incubated in a humid atmosphere for
60 min at 37C in the dark. After three PBS washes, the
cell arrays were mounted for ﬂuorescence microscopy or a
scanner analysis. Alternatively, AlexaFluor 488-conjugated
anti-Fluorescein/Oregon Green goat antibody (Molecular
Probes) was used as a secondary antibody to amplify the
ﬂuorescence signal while still allowing ﬂuorescein-com-
patible optics.
Annexin V
The cell arrays were washed once with the PBS containing
Ca
2? (Gibco, Invitrogen) to remove the culture medium,
followed by a wash with the Annexin V binding buffer (BD
Pharmingen). The Annexin V working solution was then
added to incubate the cells for 20–30 min at room tem-
perature. For Annexin V-biotin (Caltag Laboratories), a
1:40 dilution was found optimal, whereas for Annexin V-
FITC (BD Pharmingen), even the original 109 stock
solution was found to stain the apoptotic cells weakly. The
Annexin V-biotin-labeled cell arrays were rinsed twice in
Annexin V binding buffer before being subjected to
streptavidin binding. Alexa Flour 594- or 488-conjugated
streptavidin (Molecular Probes) was freshly prepared in
Annexin V binding buffer to 3–5 lg/ml, and used to
incubate the cell arrays for 20 min at room temperature.
After the removal of the streptavidin excess by washing the
slide with Annexin V binding buffer, the apoptotic cells
were stained by Annexin V and examined by ﬂuorescence
microscopy. Alternatively, for prolonged storage, the
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123Annexin V-labeled cell arrays were ﬁxed with 4% para-
formaldehyde in PBS for 20 min at room temperature.
Cleaved caspase-3
The labeling of cleaved caspase-3 was performed with the
rabbit antibody (Cell Signaling) following the basic
immunoﬂuorescence protocol described above. In some
cases, the cleaved caspase-3 antibody was also combined
with the mouse anti-His or mouse anti-Bax antibody, to
reveal the correlations between the activation of caspase-3
and the over-expression of Chr21 and Bax proteins. In this
case, the incubation with the primary antibodies was per-
formed overnight at 4C. The Alexa488-conjugated donkey
anti-rabbit IgG and Alexa568-conjugated goat anti-mouse
IgG (Molecular Probes) were mixed and used as secondary
antibodies for the ﬂuorescence labeling.
Triple apoptosis assay
Three apoptosis assays—Annexin V, cleaved caspase-3
and the TUNEL reaction—were applied together on a
single cell array slide to collect the death signals from
different apoptosis stages in a single experiment. The cell
arrays were always labeled with Annexin V prior to the cell
ﬁxation. After the ﬁxation, the cell array slide was stored in
Annexin V binding buffer at 4C until the multiple detec-
tion. For the triple apoptosis assay, the cell arrays were ﬁrst
permeabilized with 0.1% Triton X-100 in PBS rather than
with 0.1% sodium citrate, which is used in the single
TUNEL assay. After blocking in 5% BSA, the arrays were
ﬁrst incubated overnight with rabbit cleaved caspase-3
before proceeding to the TUNEL reaction. The rest of the
basic immunoﬂuorescence protocol was then followed,
except that the composition of secondary antibodies was
modiﬁed according to the purpose of each experiment.
When it was necessary to combine the signals from cas-
pase-3 and TUNEL, the AlexaFluor488-conjugated goat
anti-rabbit and AlexaFluor488-conjugated donkey anti-
FITC secondary antibodies were used. Otherwise, the
AlexaFluor555-conjugated anti-Rabbit antibody was used
rather than the AlexaFluor488-conjugation.
Laser scanning and microscopy
To observe the ﬂuorescence signals within each cell cluster
(i.e., apoptotic cells and over-expressed proteins), a Bio-
CCD scanning system (Applied Biosystems, Darmstadt,
Germany) was used. For the cell morphology analysis and
protein subcellular localization, the ImagerZ1 microscope
(Zeiss, Jena, Germany) and LSM510 confocal system
(Zeiss) were used, together with the Axiovision 4.0 and
LSM510 software (Zeiss).
Results
Multiple apoptosis detection on cell arrays
To select a suitable apoptosis detection assay for the cell
array, a construct over-expressing the human Bax protein, a
key regulatory protein in the mitochondrial apoptotic
pathway, was ﬁrst used as a positive control for the assay
optimization. Three apoptosis assays (Annexin V, cleaved
caspase-3 antibody, and TUNEL) were found to be com-
patible with transfected cell arrays adjustments of the
respective protocols. As shown in Fig. 1a, different
Fig. 1 a The different cell death assays (as indicated) target the cells
at different stages of apoptosis. Annexin V, anti-activated Caspase-3
antibody and TUNEL were used to label the same apoptotic cell
cluster induced by Bax over-expression with different ﬂuorochromes
(as indicated). The non-overlapping signals in the merged image
(bottom) indicate different apoptotic stages of the cells. The cells in
red (a) were stained by Annexin V only, a marker for the early stage
of apoptosis; the green cells (b) were in the middle to late stages of
apoptosis, as detected by TUNEL and an antibody against activated
caspase-3. b The combined apoptosis assays collectively label the
asynchronous death signals induced by Bax over-expression. The
immunoﬂuorescence labeling using an anti-Bax antibody indicates a
cell cluster over-expressing Bax. Triple detection: combined Annexin
V, activated caspase-3 Ab and TUNEL assays. Merge: the combi-
nation of anti-Bax staining and the triple death detection. Scale bars,
100 lm
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123apoptotic cells, as a result of the Bax over-expression, were
positive to the Annexin V staining, cleaved caspase-3 and
TUNEL assays. The staining differences might originate
from the biological mechanism underlying the particular
assays. Annexin V is known to dominantly bind to the cell
plasma membrane in regions where the asymmetry of the
membrane structure has been lost. Because cell membranes
were more abundant at the early stage of apoptosis, Annexin
V binding at this stage was much more intensive compared
to the staining of cells with fragmented membranes at later
stages of apoptosis. In contrast, most of the TUNEL-sen-
sitive cells were often characterized with collapses in the
cytoplasm and nucleus, and most frequently with cell
blebbing or fragmentation, features of the very late stage of
apoptosis. Activated caspsase-3 was often detected in the
cells between the middle and early-late stage, when the
cytoplasm shrank and the nucleus lost its integrity, but prior
to fragmentation (Fig. 1a). Due to their differential sensi-
tivities, the three assays (Annexin V, cleaved caspase-3 and
TUNEL), when used with separate ﬂuorochromes, allowed
us to identify different stages of the cell death pathway. On
the other hand, all three assays could be used simulta-
neously (triple death assay) with the same color ﬂuoro-
chrome to collect the asynchronous apoptotic signals
ranging from the early to late stage, as shown in Fig. 1b.
This was of particular use in this study to investigate the
apoptosis-inducing effects of human Chr21 proteins on
Hek293T cell arrays, where false-negatives might be pres-
ent due to the relatively low efﬁciency of transfection.
The over-expression of two Chr21 proteins (claudin-8
and -14) induced cell death through a non-apoptotic
pathway
The triple apoptosis assay was subsequently applied to
study Chr21 proteins for possible apoptosis-inducing
effect. Cells over-expressing claudin-8 and -14 were found
to be extensively labeled, whereas claudin-17 showed
negative staining. As shown in Fig. 2, 48 h after the
reverse transfection, over 70% of the cells over-expressing
claudin-14 were positively stained by the triple assay,
whereas none of the cells over-expressing claudin-17 were
stained. In the subsequent time-course experiments per-
formed in both Hek293T and HeLa cells at 24, 48 and 72 h
after transfection, at least a 70% positive staining was
obtained for the claudin-14-transfected cells irrespective of
the transfection time and cell lines (data not shown).
To determine whether these results were cell array-
dependent, normal transfections of the three claudins were
performed in a 6-well plate format and the triple death
assay was performed on cells ﬁxed on a glass cover slip.
Again, most of the cells over-expressing claudin-14 or -8
were tested positively for cell death, whereas only few
cells, undergoing spontaneous apoptosis, were found in the
case of the claudin-17 transfection (data not shown). The
ﬁndings from both the cell array and normal transfection
experiments strongly suggest that the over-expression of
claudin-8 and -14 but not claudin-17 leads to extensive cell
death. Interestingly, in the previous protein subcellular
localization study, claudin-8 and -14 had been found pre-
dominantly in the ER instead of the plasma membrane,
where tight-junction proteins (including claudin-17) local-
ize [13]. Hence, the ER retention of claudin-8 and -14
likely correlates with the cell death induced by their over-
expression.
Separate use of the assays revealed a non-apoptotic
form of cell death
Despite the cell shrinkage and nuclear DNA degradation,
the additional typical apoptosis features, such as cell
blebbing, were not observed in the dying cells following
the claudin-8 or -14 over-expression. We next asked
Fig. 2 The over-expression of claudins leads to programmed cell
death. The over-expression of claudin-14 (a), but not claudin-17 (b),
resulted in a positive detection by the ‘‘triple death assay’’. Upper
images: the cell clusters transfected with a plasmid coding for
claudin-14 (upper left) or claudin-17 (upper right). The expressed
proteins were labeled with an anti-His antibody that was conjugated
to a green ﬂuorophor. Middle images: the simultaneous detection of
the same cell clusters by Annexin V, the activated Caspase-3 antibody
and TUNEL with red ﬂuorescence. Merged images: the combination
of anti-His staining and death detection. The yellow cells in the left
image indicate cell death as a result of claudin-14 over-expression.
Scale bars, 200 lm
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123whether the cell death induced by the two claudins was a
classic type of apoptosis. Annexin V, activated caspase-3,
and TUNEL assays were separately applied to determine
the origin of the detection signals and thus to elucidate the
type and possible mechanism of the induced cell death. In
the cells transfected by claudin-8 or -14, Annexin V rather
than the other two assays was found to largely contribute to
the positive labeling within the ‘‘triple death assay’’. Under
a higher magniﬁcation, Annexin V was found to bind
speciﬁcally to the outer leaﬂets of the cell membrane that
wrapped the condensed ER where claudin-14 localized
(Fig. 3a). Moreover, the nuclear DNA of the dying cells
appeared to degrade as the DAPI staining greatly
decreased. For the cells at the late death stage (the
cytoplasm extremely condensed), the nuclear DNA was
barely stained by DAPI (Fig. 3b). TUNEL-positive stain-
ing, however, was only observed in few cells over-
expressing the claudins (Fig. 4), suggesting the DNA
fragmentation is not compulsory for the claudin-induced
cell death. Surprisingly, caspase-3, an essential processor
for classic apoptosis, was found not to be actively cleaved
in the dying cells induced by the two claudins (Fig. 5).
Moreover, the typical apoptotic phenotypes, such as cell
blebbing and the formation of apoptotic bodies, were not
found in the case of the claudin-induced cell death. These
results were conﬁrmed by normal transfections subjected to
separate detection assays. Thus, it might be hypothesized
that the cell death process resulting from claudin-8 and -14
Fig. 3 The cell death induced by claudin-14 over-expression is
positive to Annexin V. Annexin V was found to bind speciﬁcally to
the outer leaﬂets of the cell membrane where the membrane
asymmetry was lost due to claudin-14 over-expression (a, b). In the
cells over-expressing claudin-14, the nuclear DNA degraded and was
barely stained by DAPI (arrow). Green ﬂuorescence: the over-
expressed claudin-14 labeled with an Alexa488-conjugated antibody
against the His6 epitope fused to claudin-14. Red ﬂuorescence: biotin-
conjugated Annexin V bound to Alexa594-conjugated streptavidin.
Merge: the combination of claudin-14, Annexin V, and DAPI
staining. Scale bars, 20 lm
Fig. 4 The cell death induced by claudin-14 over-expression is only
partially positive to TUNEL. The DNA fragmentation detected by
TUNEL reaction was observed in some (a) but not all of the cells
over-expressing the claudins (b). (c) A spontaneous apoptotic cell
positive to the TUNEL reaction. Red ﬂuorescence: the over-expressed
claudin-14 labeled with Alexa555-conjugated antibody against the
His6 epitope fused to claudin-14. Green ﬂuorescence: the FITC-
conjugated TUNEL reaction. PC: Phase contrast. Merge-1: the
combination of claudin-14, TUNEL, and DAPI staining. Merge-2: the
combination of merge-1 and phase contrast. Scale bars, 20 lm
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123over-expression occurs via an alternative pathway that is
independent of the classic caspase-mediated apoptosis.
Discussion
The claudin multigene family comprises tetraspan mem-
brane proteins which are important structural and func-
tional elements of tight junctions. Claudins have important
roles in regulating paracellular permeability and main-
taining cell polarity in epithelial and endothelial cells [15].
In mammals, there are 24 members of the claudin family,
showing a complex pattern of tissue-speciﬁc expression
[16]. Claudins extracellular loops from neighboring cells
interact with each other to maintain integrity of the cellular
sheet. They also regulate paracellular transport between the
luminal and basolateral compartments. The claudins
interact with a number of proteins and are involved in
signal transduction to and from the tight junction [17]. Loss
of human claudin-14 is known to cause autosomal reces-
sive deafness [18].
The claudin-related non-classic cell death pathway was
previously described during epidermal development in the
early embryogenesis of vertebrates. Claudin-1 was found to
localize in the periderm and the subperiderm of the chicken
embryo, and its function in tight junctions was involved in
the formation of the embryonic diffusion barrier, which is
lost by desquamation at the end of the embryonic period.
Interestingly, a special form of programmed cell death was
found to account for the desquamation of the embryonic
diffusion barrier. The cell death occurring at the periderm
and the subperiderm was partially positive to TUNEL,
whereas the activity of caspase-3, -6, and -7 was found to
be absent [19]. This type of cell death was very similar to
the one induced by claudin-8 and -14 over-expression in
this study.
Taken together, these results suggest a previously
undescribed functional relationship between the claudins
and the control of the cell cycle and regulation of the cell
death induction mechanism.
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